AgeX Therapeutics, Inc. (AGE)

Revenue Growth

-100.00%

TTM · Period ending:

AGE logo

AGE Revenue Growth

Year-over-year change vs the same period a year earlier

Latest reported-100.00%
AGE TTM Revenue YoY % (23.78% → -100.00%)
High-resolution chart · PNG

AGE revenue growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Revenue Growth — Trailing twelve months (TTM)
Period endingRevenue Growth
-100%
47.7273%
39.7849%
-28.8344%
5.6962%
-24.1379%
-23.1405%
123.2877%
338.8889%
197.4359%
255.8824%
37.7358%
-47.0588%
-58.0645%
-76.3889%
-91.4791%
-93.4109%
-93.3996%
-92.2912%
-67.4686%
-45.3679%
-24.0431%
8.1019%
28.1501%
29.295%
20.0647%
23.7822%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.